Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
5.27 | 14745880 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
5.10 | 17451421 17308373 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.60 | 15800139 |
MESH:D000855 |
Anorexia |
|
N-Methyl-3,4-methylenedioxyamphetamine |
5.71 | 15146954 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
5.16 | 15014928 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
5.04 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.06 | 12006526 11325840 17020986 17388661 18323546 18234424 16978400 15136595 15093573 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.06 | 16837676 15572757 16912660 15758505 17595753 17893378 17242785 15775269 17952589 17440819 17049068 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.06 | 17242785 18351453 18629630 19189210 19142967 17893378 16202921 18815881 19059307 11161223 16273361 18855134 17440819 19155303 15565566 20544844 19487384 19221464 19200415 19011961 18997820 19084267 16873071 20135344 18425577 19115204 21138602 19189212 17261762 20390343 18821012 15668708 20005174 19244106 20859285 18984771 19066611 19289846 19288272 21152245 19103187 20065188 16818667 19410462 17049068 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
5.07 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
3.44 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
3.44 | 16924424 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
5.52 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
3.69 | 16201981 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
10.84 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
10.84 | 17572228 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.71 | 15775269 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
5.18 | 15800139 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.71 | 16989017 12161096 16651033 15643279 17979934 18372110 18483878 10498854 12388444 18093676 16413132 12913760 18710439 18433785 18295254 16614059 10700343 15276878 11948286 17010015 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.92 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.53 | 17474826 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.41 | 11751995 10990075 15331540 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.31 | 18772604 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
10.28 | 17451421 15920148 17308373 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
10.28 | 19279558 |
MESH:D004487 |
Edema |
|
Raloxifene |
3.76 | 15860553 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
10.98 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
10.98 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.29 | 16202921 20544844 19155303 17893378 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.77 | 11006010 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
9.43 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
9.43 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.45 | 16709447 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
5.16 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.81 | 19069698 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
6.15 | 11389073 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.60 | 16376943 11014644 15172196 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.80 | 11110106 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.85 | 11918545 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
6.26 | 14986274 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
4.15 | 16135485 17606976 |
OMIM:149400 |
HYPEREKPLEXIA, HEREDITARY |
marker/mechanism |
|
| |
MESH:D006973 |
Hypertension |
|
Raloxifene |
2.98 | 15787275 17577099 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
6.05 | 16076520 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
3.87 | 16517039 7193160 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
2.53 | 19457130 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
3.38 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.96 | 16973256 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
3.66 | 10602166 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.63 | 18172266 17802794 17296974 17658394 18587576 17008537 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.38 | 10373061 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
5.60 | 11830472 10052129 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.43 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
1.75 | 18564211 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
2.33 | 16684651 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
1.74 | 18625569 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
4.11 | 12854902 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
5.06 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
4.51 | 11911406 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.39 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.86 | 11731420 19196722 14580682 19196723 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
5.27 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.92 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.81 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
5.36 | 16388313 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
6.28 | 15863610 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.71 | 16497877 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
6.28 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.67 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.61 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
3.29 | 18854779 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.72 | 19200415 19196722 19189210 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.81 | 8761367 15176712 16115947 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
5.52 | 8761367 12837982 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.79 | 8291058 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
5.34 | 16517039 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.61 | 19059307 17882678 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.69 | 17823083 15579764 17893378 15758505 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.96 | 18093676 12161096 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
3.29 | 11332152 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
4.00 | 21297632 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.64 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.64 | 16220300 15731164 16536755 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.64 | 15067354 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.40 | 16636934 |
MESH:D011693 |
Purpura |
|
Raloxifene |
6.28 | 15770314 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
5.28 | 16636934 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
5.02 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
6.15 | 16517039 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.67 | 19457130 |
MESH:D020521 |
Stroke |
|
Raloxifene |
4.15 | 16837676 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.69 | 12837982 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.93 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
9.22 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
9.22 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
9.22 | 16712894 8653321 17572228 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.93 | 16837676 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
6.28 | 16343187 |